Staging anti-inflammatory therapy in Alzheimer´s disease
The use of non steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer´s disease (AD) is controversial because conclusions from numerous epidemiological studies reporting delayed onset of AD in NSAID users have not been corroborated in clinical trials. The purpose of this personal view is t...
Main Author: | Elena eGalea |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2010-10-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2010.00142/full |
Similar Items
-
Non-Steroidal Anti-inflammatory Drugs (NSAIDs): Synthesis of Ibuprofen, Naproxen and Nabumetone
by: Ayad M. R Raauf, et al.
Published: (2019-08-01) -
Outcomes of nonsteroidal anti‐inflammatory drug toxicosis treated with therapeutic plasma exchange in 62 dogs
by: Emmanuelle M. Butty, et al.
Published: (2022-09-01) -
Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
by: Nolan V. Chalifoux, et al.
Published: (2023-01-01) -
Synthesis, In Vitro Anti-Inflammatory Activity, and HRMS Analysis of New Amphetamine Derivatives
by: Stanimir Manolov, et al.
Published: (2022-12-01) -
The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease
by: Celia G. Fernandez, et al.
Published: (2019-02-01)